New Mechanism Can Disarm Attacking Immune Cells

A novel mechanism has been identified that is used by the pancreatic cancer cells to disarm macrophages, which attack immune cells.

New mechanism identified disarms the macrophages that attack the immune cells. A substance called Gdf-15 released by pancreatic tumor cells suppresses macrophage during early tumor development, reveals a new study.//

The study found that the substance Gdf-15, might be required for the development of early pancreatic tumors. The research also revealed that a molecule pronounced N-F-kappa-B (NF-kB) helps tumor cells produce Gdf-15.

‘GDF-15 released from pancreatic tumor cells inhibits NF-kB activity in macrophages that blocks them from killing tumor cells.’

The new study was by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James).

When macrophages take up Gdf-15, it prevents them making nitric oxide and tumor necrosis factor, two chemicals they release to kill cancer cells. Ironically, the researchers found that NF-kB in macrophages plays an important role in the production of nitric oxide and tumor necrosis factor.

The findings are reported in the Journal of Clinical Investigation.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

"This study shows that GDF-15 plays an important role in the development of pancreatic cancer and might be required for the development of early pancreatic tumors," says principal investigator Denis Guttridge, PhD, professor of Cancer Biology and Genetics at Ohio State and associate director for basic research.

"We believe that this mechanism for disarming macrophages develops early in cancer cells, enabling small tumors to survive and grow," adds Guttridge, who also is in the OSUCCC - James Molecular Carcinogenesis and Chemoprevention Program.

An Electronic Nose to Detect Pancreatic Cancer
An electronic nose could be an efficient screening method for the diagnosis of pancreatic cancer, says study.

"These findings support the need for preclinical studies to determine the role of GDF-15 in the development of pancreatic cancer."

Guttridge and his colleagues conducted the study using pancreatic-cancer cell lines, cells from patient tumors and an animal model.

World Pancreatic Cancer Day 2017: Demand Better. For Patients. For Survival
The World Pancreatic Cancer Day is being celebrated on November 16, 2017, aims to early diagnosis and improve outcomes for the patient.

Key findings include:

NF-kB is a direct regulator of Gdf-15
GDF-15 suppresses macrophage cell-killing activity by inhibiting the production of nitric oxide and tumor necrosis factor
Both GDF-15 and NF-kB are overexpressed in patients with pancreatic cancer

"Overall," Guttridge says, "our results reveal that NF-kB is responsible for the synthesis and secretion of GDF-15 from pancreatic tumor cells, and that GDF-15 then inhibits NF-kB activity in macrophages and blocks them from killing tumor cells."

Source-Eurekalert